In Africa, Dealing With Vaccine Challenges and the Omicron Variantnews2021-12-03T21:55:34+00:00December 3rd, 2021|The New York Times|
Will High Vaccination Rates Help Spain Weather Omicron?news2021-12-02T18:14:26+00:00December 2nd, 2021|The New York Times|
What Can One Life Tell Us About the Battle Against H.I.V.?news2021-12-02T10:00:16+00:00December 2nd, 2021|The New York Times|
Omicron Is Here. Will We Use Our New Covid Drugs Wisely?news2021-12-01T23:11:37+00:00December 1st, 2021|The New York Times|
Build Back Better Act Would Patch Holes in Health Coveragenews2021-12-01T10:00:25+00:00December 1st, 2021|The New York Times|
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panelnews2021-12-01T00:23:13+00:00December 1st, 2021|The New York Times|
South African Company Nears License to Sell J. & J. Covid Shot Across Africanews2021-11-30T21:07:51+00:00November 30th, 2021|The New York Times|
¿Las vacunas funcionan para la variante ómicron?news2021-11-29T23:50:30+00:00November 29th, 2021|The New York Times|
Antiviral Covid-19 Pills Are Coming. Will There Be Enough Tests?news2021-11-29T19:40:28+00:00November 29th, 2021|The New York Times|
Will the Vaccines Stop Omicron? Scientists Are Racing to Find Out.news2021-11-28T23:55:10+00:00November 28th, 2021|The New York Times|
